Astrazeneca Pharma India's Stock Price Soars, Outperforms Sector and Market.
Astrazeneca Pharma India, a midcap pharmaceutical company, saw a significant increase in its stock price on October 7th, 2024. It closed at Rs 8099.4, gaining 8.72%. The stock has outperformed the sector by 8.36% and maintained a higher position than its moving averages. It has also outperformed the Sensex by a significant margin.
Astrazeneca Pharma India, a midcap pharmaceutical company, has seen a significant increase in its stock price on October 7th, 2024. The stock has gained 8.72%, closing at Rs 8099.4. This performance has caught the attention of MarketsMOJO, who have given a 'Hold' call for the stock.
The stock is currently trading close to its 52-week high of Rs 8139.85, with a difference of only 0.96%. It has also outperformed the sector by 8.36% today. This is a positive sign for investors, as the stock has been on a downward trend for the past three days.
Astrazeneca Pharma India has shown high volatility today, with an intraday volatility of 6.73%. However, it has managed to maintain a higher position than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This indicates a strong performance by the company.
In comparison to the overall market performance, Astrazeneca Pharma India has outperformed the Sensex by a significant margin. Its 1-day performance is 7.93% compared to Sensex's 0.17%, and its 1-month performance is 16.58% compared to Sensex's 0.80%.
Overall, Astrazeneca Pharma India has shown a strong performance in the stock market, with a significant increase in its stock price and outperforming the sector and market. Investors may want to keep an eye on this midcap company as it continues to show promising growth.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
